Skip to content

Clinical trials

Polyradiculoneuropathy, Chronic Inflammatory Demyelinating trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Polyradiculoneuropathy, Chronic Inflammatory Demyelinating Country / region: Belgium Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20122
20171
20192
20202
20221
20231
20242
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Recruiting4
Terminated3
Active, not recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Immunovant Sciences GmbH3
CSL Behring2
Sanofi2
argenx2
Centre Hospitalier Universitaire de Liege1
Dianthus Therapeutics1
Novartis Pharmaceuticals1
Pfizer1
UCB Biopharma S.P.R.L.1
UCB Biopharma SRL1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating15
Autoimmune Diseases2
Autoimmune Diseases of the Nervous System1
Nervous System Diseases1
Polyradiculoneuropathy1
Purpura, Thrombocytopenic, Idiopathic1

Trials

Showing 26 to 15 of 15. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.